Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.
Follow-Up Questions
What is Poniard Pharmaceuticals Inc (PARD)'s P/E Ratio?
The P/E ratio of Poniard Pharmaceuticals Inc is 0
What is the price performance of PARD stock?
The current price of PARD is $0.0001, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Poniard Pharmaceuticals Inc?
Poniard Pharmaceuticals Inc belongs to Biotechnology industry and the sector is Health Care
What is Poniard Pharmaceuticals Inc market cap?
Poniard Pharmaceuticals Inc's current market cap is $150
